At the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/OD), during the 'Abeta Targeting Therapies in AD' symposium on 3 April, Roche presented interim trial ...

that a buildup of amyloid beta in the brain is the root cause of the disease. Known as the amyloid hypothesis, this theory emerged in the 1980s after researchers identified amyloid plaques as a ...

Although there are many outstanding questions about Alzheimer’s and a significant lack of effective drugs, scientists believe a protein called amyloid-beta plays an important role in the condition.

Credit: Lightspring / Shutterstock. At the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/OD), during the ‘Abeta Targeting Therapies in AD’ symposium on 3 April, Roche ...

That view is informed by data on the first wave of successful anti-amyloid-beta antibodies. Roche is hoping to improve on those molecules by pairing its antibody with technology for crossing the ...

Labcorp's pTau-217/Beta Amyloid 42 Ratio blood test meets the performance criteria to confirm amyloid pathology consistent with Alzheimer's disease BURLINGTON, N.C., April 2, 2025 /PRNewswire ...

An illustration depicts cells in an Alzheimer’s-affected brain, with abnormal levels of beta amyloid protein clumping together to form plaques that collect between neurons and disrupt cell function.

"These exciting preliminary findings hint very clearly at the potential role of lowering beta amyloid in prevention of Alzheimer's disease," said Maria C. Carrillo, PhD, Alzheimer's Association ...

“These exciting preliminary findings hint very clearly at the potential role of lowering beta amyloid in prevention ... Bateman RJ, Li Y, McDade EM, et al. Safety and efficacy of long-term ...